Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Arimidex anastrozole: Phase III data; marketed to treat advanced breast cancer that has progressed following tamoxifen therapy

AstraZeneca presented previously reported data from its European and North

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE